comparemela.com

Latest Breaking News On - European hematology association congress - Page 5 : comparemela.com

Vertex to Present New Data on Exagamglogene Autotemcel (exa-cel) at the American Society of Hematology (ASH) Annual Meeting and Exposition

- New data including longer duration follow-up from SCD and TDT pivotal trials accepted for oral presentation – - Five additional abstracts accepted for poster presentation - .

Boston
Massachusetts
United-states
Australia
London
City-of
United-kingdom
America
American
Exagamglogene-autotemcel
Instagram
Vertex-pharmaceuticals-incorporated-nasdaq

FDA completes meeting for potential genetic therapy to treat sickle cell disease

FDA completes meeting for potential genetic therapy to treat sickle cell disease
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Carmen-bozic
European-hematology-association-congress
Gene-therapies-advisory-committee
Drug-administration
Vertex-pharmaceutical

Venetoclax Plus Dexamethasone Misses PFS End Point in t(11;14)+ R/R Multiple Myeloma

The combination of venetoclax and dexamethasone failed to significantly improve progression-free survival over pomalidomide plus dexamethasone in patients with t(11;14)-positive, relapsed or refractory multiple myeloma who have previously received at least 2 therapies.

San-diego
California
United-states
Netherlands
Amsterdam
Noord-holland
Venclexta-venclyxto
Mariana-cota-stirner
International-myeloma-working-group
European-hematology-association-congress
With-pomdex
Cota-stirner

Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia

Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada
Norway
Iceland
Liechtenstein
Japan
Vienna
Wien
Austria
United-states
Tokyo
American
Otsuka-europe

Astex Pharmaceuticals, Inc.: Otsuka and Astex announce that the European Commission has approved INAQOVI (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia

Astex Pharmaceuticals, Inc.: Otsuka and Astex announce that the European Commission has approved INAQOVI (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Canada
Japan
Iceland
Tokyo
Vienna
Wien
Austria
Steigen
Nordland
Norway
United-states
Liechtenstein
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.